Company

BioTime is committed to leading the next revolution in regenerative medicine. Over the past several years, we have made significant progress in building a dominant company in this exciting field. Our strategy is to be the leader in the development of pluripotent stem cell-based technologies and to apply those new technologies in the treatment of degenerative diseases that afflict large numbers of people worldwide.

 

Pluripotent cell graphic